MedPAC Considers Setting Up Oncology Drug Copay Fund

Why This Topic Matters

The topic affects how cancer drug costs are handled for Medicare beneficiaries and how oncology practices manage drug acquisition and delivery under Medicare payment policy. It is useful for readers monitoring reimbursement policy, beneficiary assistance initiatives, and CMS program adjustments.

Article Sections

1. MedPAC proposes interim copayment assistance for Part B drugs

   Discusses a MedPAC recommendation related to beneficiary help with Medicare Part B drug copayments and the broader policy context behind the proposal.

2. Oncology drug payment and review of ASP-based pricing

   Summarizes the article’s discussion of oncology practice payment concerns and planned review activity involving federal oversight and pricing methodology.

3. Competitive Acquisition Program exception for rural satellite offices

   Covers a proposed CMS program adjustment related to drug delivery logistics for practices using the Competitive Acquisition Program, with attention to rural clinic operations.